Bristol-Myers Squibb Co (NYSE:BMY)

59.06
Delayed Data
As of 4:10pm ET
 -0.52 / -0.87%
Today’s Change
42.48
Today|||52-Week Range
68.34
-7.99%
Year-to-Date
Here's How Nektar Therapeutics Performed in Q4
7:00am / MotleyFool.com - Paid Partner Content
3 Cancer Treatment Stocks to Buy Right Now
Feb 23 / MotleyFool.com - Paid Partner Content
Where Will Johnson & Johnson Be in 1 Year?
Feb 26 / MotleyFool.com - Paid Partner Content
A Big Month Ahead for the FDA and Bristol-Myers Squibb
Feb 22 / MotleyFool.com - Paid Partner Content
Here's Why Karyopharm Therapeutics Has a Unique Growth Opportunity
Feb 26 / MotleyFool.com - Paid Partner Content
FDA Approved 1,014 Generic Drugs in 2019
Feb 19 / MotleyFool.com - Paid Partner Content
3 Value Stocks to Buy if the Stock Market Implodes
Feb 25 / MotleyFool.com - Paid Partner Content
Why bluebird bio's Q4 Results Really Don't Matter
Feb 19 / MotleyFool.com - Paid Partner Content
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Feb 23 / MotleyFool.com - Paid Partner Content
Better Buy: GlaxoSmithKline vs. Bristol-Myers Squibb
Feb 16 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close59.58
Today’s open57.76
Day’s range56.37 - 59.21
Volume28,122,024
Average volume (3 months)17,080,603
Market cap--
Data as of 4:10pm ET, 02/28/2020

Growth & Valuation

Earnings growth (last year)-33.05%
Earnings growth (this year)+30.23%
Earnings growth (next 5 years)+8.29%
Revenue growth (last year)+15.89%
P/E ratio29.4
Price/Sales4.20
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.29+0.34%
LLYEli Lilly and Co-3.06-2.37%
SNYSanofi-1.91-3.97%
AZNAstraZeneca-1.27-2.82%
Data as of 4:10pm ET, 02/28/2020

Financials

Next reporting dateApril 23, 2020
EPS forecast (this quarter)$1.46
Annual revenue (last year)$26.1B
Annual profit (last year)$3.4B
Net profit margin13.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts